Published in Arch Surg on August 01, 1973
A prospective comparative trial between early endoscopy and radiology in acute upper gastrointestinal haemorrhage. Gut (1975) 1.95
Prospective comparison of double-contrast barium meal examination and fibreoptic endoscopy in acute upper gastrointestinal haemorrhage. Br Med J (1976) 1.82
The role of the surgeon in the evolution of flexible endoscopy. Surg Endosc (2006) 1.09
Upper GI bleeding in an urban hospital. Etiology, recurrence, and prognosis. Ann Surg (1990) 0.94
Upper gastrointestinal bleeding in cirrhosis: clinical and endoscopic correlations. Gut (1976) 0.90
Radiology and endoscopy in acute upper gastrointestinal bleeding. Br Med J (1976) 0.82
Letter: Massive upper gastrointestinal bleeding. Br Med J (1974) 0.82
Emergency diagnosis of upper gastrointestinal bleeding by fiberoptic endoscopy. Ann Surg (1977) 0.77
Letter: Radiology and endoscopy in acute upper gastrointestinal bleeding. Br Med J (1976) 0.75
Choice of treatment in the management of bleeding oesophageal varices in patients with cirrhosis. Ulster Med J (1978) 0.75
Prognostic factors in breast cancer. College of American Pathologists Consensus Statement 1999. Arch Pathol Lab Med (2000) 4.67
2000 update of recommendations for the use of tumor markers in breast and colorectal cancer: clinical practice guidelines of the American Society of Clinical Oncology. J Clin Oncol (2001) 3.25
Relationship of patient age to pathologic features of the tumor and prognosis for patients with stage I or II breast cancer. J Clin Oncol (1994) 2.77
The sequencing of chemotherapy and radiation therapy after conservative surgery for early-stage breast cancer. N Engl J Med (1996) 2.74
Endoscopic complications. Results of the 1974 American Society for Gastrointestinal Endoscopy Survey. JAMA (1976) 2.55
Elevated levels of an angiogenic peptide, basic fibroblast growth factor, in the urine of patients with a wide spectrum of cancers. J Natl Cancer Inst (1994) 2.50
Mycotic aneurysm. New concepts in therapy. Arch Surg (1983) 2.30
The pharmacogenetics research network: from SNP discovery to clinical drug response. Clin Pharmacol Ther (2007) 2.18
The measurement and therapeutic implications of circulating tumour cells in breast cancer. Br J Cancer (2006) 2.14
Natural history and surgical dilemma of "stress" gastric bleeding. Arch Surg (1971) 2.13
Comparison of circulating CA15-3 and carcinoembryonic antigen levels in patients with breast cancer. J Clin Oncol (1986) 1.94
The natural and unnatural history of pancreatic pseudocysts. Br J Surg (1975) 1.91
Amplification and expression of the epidermal growth factor receptor gene in human glioma xenografts. Cancer Res (1988) 1.89
Altered coagulation after albumin supplements for treatment of oligemic shock. Arch Surg (1979) 1.81
New prognostic factors for breast cancer recurrence. Semin Oncol (2001) 1.77
Regionalization of critical care medicine: task force report of the American College of Critical Care Medicine. Crit Care Med (1994) 1.76
The MtrD protein of Neisseria gonorrhoeae is a member of the resistance/nodulation/division protein family constituting part of an efflux system. Microbiology (1997) 1.76
A pilot trial assessing the efficacy of paroxetine hydrochloride (Paxil) in controlling hot flashes in breast cancer survivors. Ann Oncol (2000) 1.72
Prognostic significance of plasma vascular endothelial growth factor levels in patients with hormone-refractory prostate cancer treated on Cancer and Leukemia Group B 9480. Clin Cancer Res (2001) 1.72
Activation of the sphingomyelin cycle through the low-affinity neurotrophin receptor. Science (1994) 1.71
Vascular endothelial growth factor and basic fibroblast growth factor urine levels as predictors of outcome in hormone-refractory prostate cancer patients: a cancer and leukemia group B study. Cancer Res (2001) 1.71
Pulmonary effects of albumin resuscitation for severe hypovolemic shock. Arch Surg (1978) 1.70
Effects of albumin versus non-albumin resuscitation on plasma volume and renal excretory function. J Trauma (1978) 1.68
The world's best-known surgeon. Surgery (1983) 1.67
Cardiac effects of adjuvant doxorubicin and radiation therapy in breast cancer patients. J Clin Oncol (1998) 1.59
Upper GI foreign body: an adult urban emergency hospital experience. Surg Endosc (2006) 1.59
Critical decisions in liver trauma. Experience based on 604 cases. Arch Surg (1970) 1.55
Eosinophilic abscess and eosinophilic pseudotumor presenting as bile duct masses: a report of 2 cases. Surgery (2001) 1.55
Prospective evaluation of hemostatic techniques for liver injuries. J Trauma (1976) 1.50
Diagnosis and treatment of pancreatic and duodenal injury. Surg Clin North Am (1977) 1.49
Use of a murine monoclonal antibody for detection of circulating plasma DF3 antigen levels in breast cancer patients. J Clin Invest (1985) 1.49
Gastrojejunostomy: is it helpful for patients with pancreatic cancer? Surgery (1987) 1.46
Diagnosis and removal of cecal whipworm infection: case report and review. Dig Dis Sci (2000) 1.46
A SNP in steroid receptor coactivator-1 disrupts a GSK3β phosphorylation site and is associated with altered tamoxifen response in bone. Mol Endocrinol (2011) 1.45
Dose-response in the treatment of breast cancer: a critical review. J Clin Oncol (1988) 1.43
Cytochrome P450 2D6 activity predicts discontinuation of tamoxifen therapy in breast cancer patients. Pharmacogenomics J (2009) 1.43
Endoscopic hemostasis of bleeding of the upper gastrointestinal tract by local injection of ninety-eight per cent dehydrated ethanol. Surg Gynecol Obstet (1986) 1.40
When is a tumor marker ready for prime time? A case study of c-erbB-2 as a predictive factor in breast cancer. J Clin Oncol (2001) 1.39
Estrogen receptor genotypes, menopausal status, and the lipid effects of tamoxifen. Clin Pharmacol Ther (2007) 1.39
We may be lost, but we're sure makin' good time. Cancer Invest (1993) 1.38
Comparison of CA15-3 and carcinoembryonic antigen in monitoring the clinical course of patients with metastatic breast cancer. Cancer Res (1988) 1.34
Differential serum protein changes following supplemental albumin resuscitation for hypovolemic shock. J Trauma (1980) 1.32
Recombinant human stem cell factor (kit ligand) promotes human mast cell and melanocyte hyperplasia and functional activation in vivo. J Exp Med (1996) 1.27
The surgical management of hepatic trauma and its complications. Ann R Coll Surg Engl (1969) 1.27
Cholecystectomy in patients with cirrhosis. A surgical challenge. Arch Surg (1985) 1.24
The effect of albumin resuscitation for shock on the immune response to tetanus toxoid. J Surg Res (1982) 1.23
Complications associated with esophagogastroduodenoscopy and with esophageal dilation. Gastrointest Endosc (1976) 1.22
Pancreatic ascites: recognition and management. Arch Surg (1976) 1.22
Factors influencing outcome after blunt duodenal injury. J Trauma (1975) 1.22
Structural homology between the Rap30 DNA-binding domain and linker histone H5: implications for preinitiation complex assembly. Proc Natl Acad Sci U S A (1998) 1.21
Massive steroids do not reduce the zone of injury after penetrating spinal cord injury. J Trauma (1994) 1.20
The surgical implications of estrophile protein estimations in carcinoma of the breast. Surgery (1976) 1.19
Primary hemostasis after massive transfusion for injury. Am Surg (1982) 1.19
Founder's lecture: The mythology of hepatic trauma--or Babel revisited. Am J Surg (1978) 1.18
Mycotic aneurysm of the carotid artery. Arch Surg (1974) 1.17
Tumor selective reactivity of a monoclonal antibody prepared against a recombinant peptide derived from the DF3 human breast carcinoma-associated antigen. Cancer Res (1992) 1.14
Mallory-Weiss syndrome. A study of 224 patients. Am J Surg (1983) 1.14
Immunoglobulin motif DNA recognition and heterodimerization of the PEBP2/CBF Runt domain. Nat Struct Biol (1999) 1.13
Obturator bypass for mycotic aneurysm in the drug addict. Arch Surg (1970) 1.13
Complications of flexible fiberoptic colonoscopy and polypectomy. Gastrointest Endosc (1975) 1.12
Gene amplification in malignant human gliomas: clinical and histopathologic aspects. J Neuropathol Exp Neurol (1988) 1.11
Do prognostic marker studies on core needle biopsy specimens of breast carcinoma accurately reflect the marker status of the tumor? Mod Pathol (1998) 1.09
Splenic abscess associated with endocarditis. Surgery (1992) 1.08
Therapeutic implications of disturbed gastric physiology in patients with stress ulcerations. Am J Surg (1972) 1.08
Worsening bone scan in the evaluation of antitumor response during hormonal therapy of breast cancer. J Clin Oncol (1995) 1.07
Clinical significance of altered coagulation tests after massive transfusion for trauma. Am Surg (1981) 1.06
Serum amylase and its isoenzymes: a clarification of their implications in trauma. J Trauma (1984) 1.06
Oligosaccharide differences in the DF3 sialomucin antigen from normal human milk and the BT-20 human breast carcinoma cell line. Cancer Commun (1989) 1.05
Altered coagulation protein content after albumin resuscitation. Ann Surg (1982) 1.05
Healing flare in skeletal metastases from breast cancer. Radiology (1994) 1.05
Eight years of experience with massive blood transfusions. J Trauma (1971) 1.04
Prediction of response to antiestrogen therapy in advanced breast cancer patients by pretreatment circulating levels of extracellular domain of the HER-2/c-neu protein. J Clin Oncol (1997) 1.04
New agents and new medical treatments for advanced breast cancer. Semin Oncol (1987) 1.04
Reactivity of monoclonal antibody DF3 with a high molecular weight antigen expressed in human ovarian carcinomas. Cancer Res (1986) 1.03
Free water clearance after supplemental albumin resuscitation for shock. Circ Shock (1989) 1.03
Biliary drainage in liver trauma. Surg Forum (1969) 1.01
Breast cancer-associated antigen, DF3/MUC1, induces apoptosis of activated human T cells. Nat Med (1996) 1.01
Emergent endoscopic retrograde cholangiopancreatography. A highly specific test for acute pancreatic trauma. Arch Surg (1989) 1.00
Plasma letrozole concentrations in postmenopausal women with breast cancer are associated with CYP2A6 genetic variants, body mass index, and age. Clin Pharmacol Ther (2011) 1.00
FADD self-association is required for stable interaction with an activated death receptor. Cell Death Differ (2006) 1.00
Liver necrosis following hepatic artery transection due to trauma. Arch Surg (1978) 1.00
Implications of fragmentation in surgery on graduate training and certification. Bull Am Coll Surg (1986) 0.99
The technique of visceral packing: recommended management of difficult fascial closure in trauma patients. J Trauma (1994) 0.99
The role of surgery in the undergraduate medical curriculum. J Med Educ (1972) 0.99
Inflammatory cytokines and aromatase inhibitor-associated musculoskeletal syndrome: a case-control study. Br J Cancer (2010) 0.99
Cysts and benign tumors of the liver. Surg Clin North Am (1977) 0.99
Analysis of randomized biliary drainage for liver trauma in 189 patients. J Trauma (1972) 0.99
CT diagnosis of perihepatic endometriosis complicated by malignant transformation. Abdom Imaging (1998) 0.98